Streetbeat News

FFNTF

4Front Ventures Corp

Employees

405

Industry

Medicinal and Botanical Manufacturing

Open

0.04

Mkt cap

35M

Volume

143K

High

0.04

P/E Ratio

-0.25

52-wk high

0.23

Low

0.03

Div yield

N/A

52-wk low

0.03

Pablo Zuanic, managing partner and senior analyst at Zuanic & Associates, has analyzed the capital expenditure (capex) strategies of 20 prominent cannabis Multi-State Operators (MSOs). Amid high interest rates and regulatory uncertainties, most companies are prioritizing cost reduction and cash flow management. However, Zuanic suggests that some MSOs with the resources should increase capex for profitable growth. Green Thumb (OTC:GTBIF) leads the way with a capex-to-sales ratio of 26% in 1H23, well above the group average of 6%. Other high capex players include MariMed (OTC:MRMD), 4Front (OTC:FFNTF), and Cresco (OTC:CRLBF).

Portfolio Pulse from Nicolás Jose Rodriguez

October 18, 2023 | 7:16 pm

On October 11, 2023, several marijuana stocks experienced significant price movements. CNBX Pharmaceuticals, Global Compliance, MJ Holdings, Item 9 Labs, Zoned Props, Heritage Cannabis Holding, Urban-gro, GreenGro Technologies, Indiva, Corbus Pharmaceuticals, Neptune Wellness Solns, Greenlane Hldgs, and Body and Mind saw their shares close up. On the other hand, Empower Clinics, Elixinol Wellness, 1933 Industries, MGC Pharmaceuticals, Curaleaf Holdings, Psychemedics, C21 Investments, Leafbuyer Techs, EnWave, Blueberries Medical, CordovaCann, Aurora Cannabis, Rocky Mountain High, SNDL, Emeren Group, Canopy Gwth, Trees, MariMed, RIV Capital, 4Front Ventures, Tilray Brands, and Auxly Cannabis Group saw their shares close down.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 9:30 pm

On October 10, 2023, several marijuana stocks experienced significant price movements. Notable gainers included Psychemedics (PMD), Target Group (CBDY), and Item 9 Labs (INLB), with shares closing up 33.22%, 27.50%, and 23.76% respectively. On the other hand, AusCann Group Holdings (ACNNF), EVIO (EVIO), and Blueberries Medical (BBRRF) were among the biggest losers, with shares closing down 69.44%, 50.00%, and 31.36% respectively.

Portfolio Pulse from Benzinga Insights

October 10, 2023 | 9:30 pm

The article lists the marijuana stocks that gained and lost on October 9, 2023. Notable gainers include EVIO, Elixinol Wellness, Psychemedics, and GrowLife. Significant losers include CNBX Pharmaceuticals, Heritage Cannabis Holding, Rocky Mountain High, and Body and Mind.

Portfolio Pulse from Benzinga Insights

October 09, 2023 | 9:30 pm

The cannabis sector experienced mixed performance on September 26, 2023, with several stocks seeing significant gains while others suffered losses. Notable gainers include GreenGro Technologies, Rocky Mountain High, iAnthus Capital Hldgs, and Urban-gro. On the other hand, Choom Holdings, Heritage Cannabis Holding, Nextleaf Solutions, and Pharmadrug were among the biggest losers.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 9:30 pm

Cannabis company 4Front Ventures Corp. has partnered with The Weldon Project, a non-profit organization advocating for federal cannabis reform. Through this partnership, 4Front has joined the Mission [Green] Alliance, supporting the nationwide campaign Round Up for Cannabis Reform. The program allows customers to round up their purchase to the nearest dollar at all Mission dispensaries to donate to The Weldon Project and Mission [Green]. The proceeds will be used for advocacy efforts for legislative reform at the federal level.

Portfolio Pulse from Nina Zdinjak

September 26, 2023 | 11:41 am

The article discusses the potential for institutional investors to migrate to cannabis stocks, with a focus on the recent HHS recommendation for rescheduling cannabis. It also covers the potential implications of the SAFE Banking Act and the impact of 280E tax provision on cannabis companies. The article features insights from executives of several cannabis companies including Glass House, TerrAscend, Verano, Village Farms, AdvisorShares' MSOS, 4Front, Trulieve, and Cresco Labs.

Portfolio Pulse from Todd Harrison

September 22, 2023 | 5:40 pm

Zuanic & Associates has analyzed the financial net debt metrics of 20 multi-state operators (MSOs) in the cannabis industry to identify potential candidates for equity raises or debt restructuring. Trulieve and Curaleaf have the highest net debt among the group. The report also includes income tax payables, gross leases, and warrant derivative liabilities in its definition of net debt, revealing that Curaleaf, Cresco, and Trulieve hold the highest absolute 'broad' net financial debt. Several MSOs, including Acreage, Ascend Wellness, AYR, Columbia Care, 4Front, iAnthus, Jushi, StateHouse, and TerrAscend, present a higher probability of needing equity raises.

Portfolio Pulse from Nicolás Jose Rodriguez

September 21, 2023 | 2:55 pm

The article lists the cannabis stocks that gained and lost on September 20, 2023. The biggest gainers were AusCann Group Holdings, Target Group, and Maple Leaf Green World, while the biggest losers were EVIO, GrowLife, and Zelira Therapeutics.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 9:30 pm

Several marijuana stocks experienced significant price movements on September 19, 2023. Notable gainers include Maple Leaf Green World, Heritage Cannabis Holding, Charlottes Web Holdings, MJ Holdings, Leafbuyer Techs, GreenGro Technologies, Cara Therapeutics, and 1933 Industries. On the other hand, stocks such as Target Group, AusCann Group Holdings, Item 9 Labs, Kaya Holdings, Curaleaf Holdings, Indiva, Greenlane Hldgs, Trulieve Cannabis, CNBX Pharmaceuticals, Cresco Labs, Canopy Gwth, Body and Mind, CLS Holdings USA, 4Front Ventures, Trees, MedMen Enterprises, Khiron Life Sciences, Zoned Props, CV Sciences, Pharmadrug, C21 Investments, Neptune Wellness Solns, GrowGeneration, Green Thumb Industries, 22nd Century Group, Tilray Brands, MariMed, and Village Farms Intl closed down.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.